Endothelial Activation by aPL: A Potential Pathogenetic Mechanism for the Clinical Manifestations of the Syndrome
Pier Luigi Meroni(IRCCS Istituto Auxologico Italiano), David C. Hess(Augusta University), Elena Raschi(IRCCS Istituto Auxologico Italiano), Munther A. Khamashta(The King's College), Cinzia Testoni(IRCCS Istituto Auxologico Italiano), Anǵela Tincani(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Ferdinando Nicoletti(University of Catania), Marina Camera(Centro Cardiologico Monzino), G. Balestrieri(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Elena Tremoli(Maria Cecilia Hospital)
Cited by 163
Related Papers
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
|Journal of Thrombosis and Haemostasis|2006|7.1k
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
The “Primary” Antiphospholipid Syndrome
|Medicine|1989|963
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913